W. David Hardy, MD, adjunct professor of medicine, Johns Hopkins University, discusses the importance of identifying patients with undiagnosed HIV and preventing new infections for accomplishing President Trump’s plan to end the HIV epidemic in 10 years. Transcript During the State of the Union, President Trump announced the ambitious plan for ending the HIV epidemic […]
HIV-negative men who have sex with men (MSM) living in Vancouver, Canada are redefining ways to negotiate sexual safety and risk, according to qualitative research recently published by Dr Benjamin Klassen and colleagues in BMC Public Health. Condoms are no longer seen as the only means of preventing HIV infection. Biomedical prevention strategies – including
HIV-negative men who have sex with men (MSM) living in Vancouver, Canada are redefining ways to negotiate sexual safety and risk, according to qualitative research recently published by Dr Benjamin Klassen and colleagues in BMC Public Health. Condoms are no longer seen as the only means of preventing HIV infection. Biomedical prevention strategies – including
Antiretroviral therapy (ART) has advanced considerably, from the approval of zidovudine (AZT) in 1987 through the emergence of triple-drug therapy and single-tablet regimens.1,2 Newer agents have fewer adverse effects and provide a life expectancy similar to individuals without HIV infection.3 With clear mortality benefits linked to ART, attention has now turned to the benefits of
Undetectable Equals Untransmittable Read More »
Philadelphia was inching closer to becoming the first city in the United States to open a safe-injection site to address the city’s opioid crisis. But the project has hit a roadblock – the U.S. Department of Justice. Pennsylvania’s top federal prosecutor last week announced he was suing the nonprofit facility called Safehouse – with timing
Future uncertain for city’s safe-injection site Read More »
The kick-off for the Simon Fraser University (SFU) Presidential Dream Colloquium generated much energy and optimism around continued advocacy for individuals living with HIV in Vancouver and across Canada-with the goal in mind of seeing an end to AIDS. However, Dr. Julio Montaner, BC-CfE Executive Director and Physician-in-Chief, warned there is a strong possibility for HIV to see a global resurgence if world leaders become complacent.
International colloquium series focuses on HIV-from cell to society Read More »
World renowned HIV/AIDS researcher and advocate for Treatment as Prevention¨, BC-CfE Executive Director and Physician-in-Chief, UBC University Killam Professor in Medicine,
Dr. Julio Montaner will receive the Senate 150th Anniversary Medal. The BC Centre for Excellence in HIV/AIDS (BC-CfE) at Providence Health Care is proud to announce Dr. Montaner is being recognized for his exemplary leadership and lifelong contribution to improving the health and lives of British Columbians.
Dr. Julio Montaner receives Senate 150th Anniversary Medal Read More »
Vancouver paramedics and firefighters receive a lot of credit for the extra burden they’ve carried since fentanyl arrived in B.C. and sent overdose calls skyrocketing. The same goes for social-service providers and staff at supervised-injection sites. To be sure, they all deserve praise. But there’s another group working to prevent deaths-one that’s a step removed
A Bangkok symposium on HIV/Aids looks at the progress being made to turn the disease from “epidemic” to “endemic” Like most member nations of the United Nations, Thailand has set itself the goal of eliminating new infections of HIV/Aids and reaching “Getting to Zero” by 2030. It is an ambition that faces many challenges. Current
The long road to zero Read More »
Funded by Health Canada, initiative to expand provincewide to curb ongoing opioid crisis and retain more individuals in opioid agonist therapy
